As veterinary telemedicine continues to expand, PetPace says its AI-powered smart collar provides clinicians with continuous, real-time physiological and behavioral data that can enhance remote patient assessments. The company believes integrating wearable biometrics into virtual care could help improve clinical decision-making, disease monitoring, and preventive care.
- PetPace is positioning its AI-powered smart collar as a solution for improving clinical decision-making during veterinary telemedicine visits.
- The wearable provides veterinarians with continuous data including heart rate, respiration, temperature, activity, and pain-related indicators during remote consultations.
- The company says integrating biometric monitoring into telemedicine can support disease management, post-surgical recovery, medication monitoring, and earlier detection of pain and stress.
- PetPace cited industry research projecting the global veterinary telemedicine market will grow from $457 million in 2022 to $1.23 billion by 2028.
- The platform also enables veterinary practices to offer branded telemedicine services through the PetPace application.
As veterinary telemedicine adoption accelerates, PetPace is highlighting the role of continuous biometric monitoring in addressing one of virtual care’s biggest limitations: the lack of objective clinical data during remote consultations.
Bridging the telemedicine data gap
The company’s AI- and machine learning-powered smart collar delivers real-time physiological and behavioral information, allowing veterinarians to monitor metrics such as heart rate, respiration, temperature, activity, and pain-related indicators while patients remain at home.
According to PetPace, combining wearable health monitoring with telemedicine gives veterinarians access to objective clinical information that would otherwise be unavailable during a standard video consultation.
PetPace Co-Founder Dr. Asaf Dagan said the technology enables clinicians to review physiological data comparable to what they would collect during an in-clinic examination while also allowing practices to provide branded telemedicine services through the company’s secure platform.
Supporting preventive veterinary care
PetPace said wearable monitoring may support post-surgical recovery, chronic disease management, medication monitoring, and earlier identification of pain, stress, and other physiological changes. The company also cited market research projecting strong growth for veterinary telemedicine through 2028.
Information sourced from the company’s press release.
